Document is current
Any future updates will be listed below
-
Authors
Esslinger, Suzan https://orcid.org/0000-0003-1052-058X
Quinn, Linda
Sampat, Sami
Otero-Lobato, Marijo
Noël, Wim
Geldhof, Anja
Herijgers, Nicole
Reeder, Sarah-Jane
-
Funding
Funding for this research was provided by:
Janssen Biologics
- License Information
-
More Information
Article History
Received: 16 November 2021
Accepted: 6 April 2022
First Online: 5 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: Suzan Esslinger is an employee of Cilag GmbH International, Switzerland; Linda Quinn, Sami Sampat, Michael Clark, Johnnie Lee, and Angela Jenkins-Zoller are employees of Janssen Research & Development, LLC, United States; Marijo Otero-Lobato, Anja Geldhof, Nicole Herijgers, Cathelijne de Gram, and Carla Morris are employees of Janssen Biologics BV, The Netherlands; Wim Noël is an employee of Janssen Cilag NV, Belgium; and Sarah-Jane Reeder and Mark Caldwell are employees of Janssen-Cilag Ltd., United Kingdom. All authors hold stock/stock options for Johnson & Johnson.
